Shionogi & Co., Ltd. (SGIOY) Financials
SGIOY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 16.2 billion | 5.6 billion |
| Dec. 31, 2025 | 11.0 billion | 1.4 billion |
| Sept. 30, 2025 | 10.9 billion | 1.2 billion |
| June 30, 2025 | 10.7 billion | 1.1 billion |
SGIOY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 540.3 million | ? |
| Dec. 31, 2025 | 194.3 million | ? |
| Sept. 30, 2025 | 322.1 million | ? |
| June 30, 2025 | 254.1 million | ? |
SGIOY Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 299.2 million |
| Dec. 31, 2025 | 476.7 million |
| Sept. 30, 2025 | 298.6 million |
| June 30, 2025 | 273.7 million |
SGIOY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 4.5 billion | - | 118.8 million |
| Dec. 31, 2025 | 1.4 billion | 114.2 million | 114.2 million |
| Sept. 30, 2025 | 1.6 billion | 122.7 million | 122.7 million |
| June 30, 2025 | 1.8 billion | - | 150.8 million |
SGIOY Shares Outstanding
SGIOY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 35.6 million | 258.5 million | 242.5 million | - |
| Dec. 31, 2025 | 10.1 million | 190.6 million | 226.5 million | - |
| Sept. 30, 2025 | 18.8 million | 186.1 million | 186.2 million | - |
| June 30, 2025 | 31.3 million | 173.1 million | 179.5 million | - |
SGIOY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 886.2 million | 208.3 million |
| Dec. 31, 2025 | 942.9 million | 163.7 million |
| Sept. 30, 2025 | 764.8 million | 117.7 million |
| June 30, 2025 | 693.8 million | 85.6 million |
SGIOY
Price: $8.65
52 week price:
Dividend Yield: 2.13%
Earnings Per Share: 0.64 USD
P/E Ratio: 15.09
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 14.9 billion